{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:45:55Z","timestamp":1778154355666,"version":"3.51.4"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"no funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,1,31]]},"DOI":"10.1080\/21645515.2021.1981086","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T13:49:17Z","timestamp":1633787357000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":57,"title":["Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study"],"prefix":"10.1080","volume":"18","author":[{"given":"Haya","family":"Omeish","sequence":"first","affiliation":[{"name":"Royal Jordanian Medical Centre- Amman-Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angam","family":"Najadat","sequence":"additional","affiliation":[{"name":"Royal Jordanian Medical Centre- Amman-Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayer","family":"Al-Azzam","sequence":"additional","affiliation":[{"name":"Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Tarabin","sequence":"additional","affiliation":[{"name":"Jordan University Hospital","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer","family":"Abu Hameed","sequence":"additional","affiliation":[{"name":"Yarmouk University","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neebal","family":"Al-Gallab","sequence":"additional","affiliation":[{"name":"University of Jordan","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel","family":"Abbas","sequence":"additional","affiliation":[{"name":"Yarmouk University","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Rababah","sequence":"additional","affiliation":[{"name":"Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majd","family":"Rabadi","sequence":"additional","affiliation":[{"name":"Ministry of Health","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema","family":"Karasneh","sequence":"additional","affiliation":[{"name":"Yarmouk University","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8148-7612","authenticated-orcid":false,"given":"Mamoon A.","family":"Aldeyab","sequence":"additional","affiliation":[{"name":"School of Applied Sciences, University of Huddersfield","place":["Huddersfield, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-020-01218-z"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2020.06.003"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab163"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e54"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060343"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.012"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31924-3"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198114"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.15190\/d.2021.1"},{"key":"e_1_3_3_11_1","unstructured":"World Health Organization. Coronavirus disease (COVID-19) [Internet]; 2021 [accessed 2021 May 30]. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"e_1_3_3_12_1","volume-title":"JFDA approves emergency use of Sputnik COVID vaccine","author":"Agency","year":"2021","unstructured":"Jordan News Agency. JFDA approves emergency use of Sputnik COVID vaccine. (Petra); 2021.\u00a0[internet]; [accessed 2021 May 30]. https:\/\/petra.gov.jo\/Include\/InnerPage.jsp?ID=32973&lang=en&name=en_news"},{"key":"e_1_3_3_13_1","first-page":"11(4):579","article-title":"Discussing the reliability and efficiency of COVID-19 vaccines","author":"Doroftei B","year":"2021","unstructured":"Doroftei B, Ciobica A, Ilie O-D, Maftei R, Mini-Review IC. Discussing the reliability and efficiency of COVID-19 vaccines. Diagnostics (Basel). 2021;11(4):579.","journal-title":"Diagnostics (Basel)"},{"key":"e_1_3_3_14_1","unstructured":"GOV.UK. Janssen publishes positive safety and efficacy data for single-dose COVID-19 vaccine [Internet]. GOV.UK2021; [accessed 2021 May 30]. https:\/\/www.gov.uk\/government\/news\/janssen-publishes-positive-safety-and-efficacy-data-for-single-dose-covid-19-vaccine?fbclid=IwAR0nmT5gGtldli6gEej-Vt8W9HfUEEU6DKP6xelHiYAVlwpa2HX6PKeMZtg."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2034577"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01230-y"},{"key":"e_1_3_3_17_1","article-title":"Vaccine adverse events: separating myth from reality","volume":"66","author":"Kimmel SR","year":"2002","unstructured":"Kimmel SR. Vaccine adverse events: separating myth from reality. Am Fam Physician. 2002;66(11):2113\u201320.","journal-title":"Am Fam Physician"},{"key":"e_1_3_3_18_1","article-title":"Reactions and adverse events of the pfizer-BioNTech COVID-19 vaccine | CDC [Internet]","author":"Centers for Disease Control and Prevention","year":"2020","unstructured":"Centers for Disease Control and Prevention. Reactions and adverse events of the pfizer-BioNTech COVID-19 vaccine | CDC [Internet]. Centers Dis Control Prev. 2020 [accessed 2021 May 30]. https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/reactogenicity.html.","journal-title":"Centers Dis Control Prev"},{"key":"e_1_3_3_19_1","article-title":"Possible side effects after getting a COVID-19 vaccine | CDC [Internet]","author":"Centers for Disease Control and Prevention","year":"2021","unstructured":"Centers for Disease Control and Prevention. Possible side effects after getting a COVID-19 vaccine | CDC [Internet]. Centers Dis Control Prev. 2021 [accessed 2021 May 30]. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/expect\/after.html.","journal-title":"Centers Dis Control Prev"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26132"},{"key":"e_1_3_3_21_1","unstructured":"European Medicines Agency. AstraZeneca\u2019s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets [Internet]; 2020 [accessed 2021 May 30]. https:\/\/www.ema.europa.eu\/en\/news\/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood."},{"key":"e_1_3_3_22_1","unstructured":"Vaccine adverse event reporting system (VAERS) [Internet]; [accessed 2021 Aug 31]. https:\/\/vaers.hhs.gov\/."},{"key":"e_1_3_3_23_1","unstructured":"Yellow card scheme - MHRA [Internet]. [accessed 2021 Aug 31]. https:\/\/yellowcard.mhra.gov.uk\/."},{"key":"e_1_3_3_24_1","unstructured":"UNHCR Jordan. COVID-19 vaccine [Internet]; 2020 [accessed 2021 Aug 31]. https:\/\/help.unhcr.org\/jordan\/en\/frequently-asked-questions-unhcr\/covid-19-vaccine\/."},{"key":"e_1_3_3_25_1","article-title":"Self-reported symptoms of SARS-CoV-2 infection in a nonhospitalized population in Italy: cross-sectional study of the EPICOVID19 web-based survey","volume":"6","author":"Adorni F","year":"2020","unstructured":"Adorni F, Prinelli F, Bianchi F, Giacomelli A, Pagani G, Bernacchia D, Rusconi S, Maggi S, Trevisan C, Noale M, et al. Self-reported symptoms of SARS-CoV-2 infection in a nonhospitalized population in Italy: cross-sectional study of the EPICOVID19 web-based survey. JMIR Public Heal Surv. 2020;6(3):e21866.","journal-title":"JMIR Public Heal Surv"},{"key":"e_1_3_3_26_1","first-page":"11","article-title":"An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: has the regional risk changed after the declaration of the state of emergency?","volume":"1","author":"Nomura S","year":"2020","unstructured":"Nomura S, Yoneoka D, Shi S, Tanoue Y, Kawashima T, Eguchi A, Matsuura K, Makiyama K, Ejima K, Taniguchi T, et al. An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: has the regional risk changed after the declaration of the state of emergency? Lancet Reg Heal West Pacific. 2020;1:11.","journal-title":"Lancet Reg Heal West Pacific"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00224-3"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30831-8"},{"key":"e_1_3_3_29_1","first-page":"1","article-title":"Adverse events in healthcare workers after the first dose of Chadox1 Ncov-19 Or Bnt162b2 Mrna Covid-19 vaccination: a single center experience","volume":"36","author":"Kim SH","year":"2021","unstructured":"Kim SH, Wi YM, Yun SY, Ryu JS, Shin JM, Lee EH, Seo KH, Lee SH, Peck KR. Adverse events in healthcare workers after the first dose of Chadox1 Ncov-19 Or Bnt162b2 Mrna Covid-19 vaccination: a single center experience. J Korean Med Sci. 2021;36:1\u20138.","journal-title":"J Korean Med Sci"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071428"},{"key":"e_1_3_3_31_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey M","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99\u2013111.","journal-title":"Lancet"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32466-1"},{"key":"e_1_3_3_33_1","unstructured":"World Health Organization. Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 SII Covishield SK Bioscience): interim guidance first issued 10 February 2021 updated 21 April 2021. World Health Organization. 2021 [accessed 2021 May 30]. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1."},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.04.047"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.15543"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02059-5"},{"key":"e_1_3_3_37_1","article-title":"Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines","volume":"2","author":"McMurry R","year":"2021","unstructured":"McMurry R, Lenehan P, Awasthi S, Silvert E, Puranik A, Pawlowski C, Venkatakrishnan AJ, Anand P, Agarwal V, O\u2019Horo JC, et al. Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines. Med (New York, NY). [Internet] 2021 [accessed. 2021 Aug 31];2. https:\/\/pubmed.ncbi.nlm.nih.gov\/34230920\/.","journal-title":"Med (New York, NY)"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphs.12370"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.1978"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2007.04448.x"},{"key":"e_1_3_3_41_1","article-title":"ICT facts and opportunities in Jordan [Internet]","author":"Telecommunication regulatory commission (TRC)","year":"2019","unstructured":"Telecommunication regulatory commission (TRC). ICT facts and opportunities in Jordan [Internet]. Amman-Jordan. 2019 [accessed 2021 Aug 18]. https:\/\/www.trc.gov.jo\/EchoBusV3.0\/SystemAssets\/PDF_Engilsh\/768e5c53-6373-4d1e-924b-118eb311f2b4_ICTFacts&OpportunitiesinJordan_HI.pdf.","journal-title":"Amman-Jordan"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1697906"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/09603123202119357782021"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06670"},{"key":"e_1_3_3_45_1","article-title":"COVID-19 vaccination and implications for gender-based violence (GBV) prevention and response - GBV WG-Jordan [EN\/AR] - Jordan | reliefWeb [Internet]","author":"UNHCR","year":"2021","unstructured":"UNHCR. COVID-19 vaccination and implications for gender-based violence (GBV) prevention and response - GBV WG-Jordan [EN\/AR] - Jordan | reliefWeb [Internet]. Guidance. 2021 [accessed 2021 Aug 18]. https:\/\/reliefweb.int\/report\/jordan\/covid-19-vaccination-and-implications-gender-based-violence-gbv-prevention-and?fbclid=IwAR2NULhF-_lLi57HpWWZtZ6A3gDeV5P_rkMd3BVXD3YLa1eXI7RC_hgqflc.","journal-title":"Guidance"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1981086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T18:59:05Z","timestamp":1744052345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1981086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,31]]}},"alternative-id":["10.1080\/21645515.2021.1981086"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1981086","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1981086"}}